Hong Kong Investment Corporation Limited

Name

Hong Kong Investment Corporation Limited

Legal name

Hong Kong Investment Corporation Limited

Website

https://hkic.org.hk

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Sovereign Patient Capital Investment

NAICS

Portfolio Management and Investment Advice (523940), Funds, Trusts, and Other Financial Vehicles (525), All Other Financial Investment Activities (52399)

SIC

Investment Advice (6282)

akta.pro primary industry

Public Asset & Investment Management (BPAIAEAG)

akta.pro secondary industries

Thematic / Sector-Focused Multi-Manager Platforms (FSANAGAH), Sustainable Private Markets (Impact PE/VC, Private Credit, Infrastructure) (FSAAALAG), Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

• Patient capital investment
• Sovereign strategic investment
• Venture capital funding
• Technology sector investment
• Biotech and green tech investment

Headquarters

HQ city

Hong Kong

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Core offering

Hong Kong Investment Corporation Limited is a government-owned Patient Capital institution that deploys HK$62 billion across four investment vehicles—the Hong Kong Growth Portfolio, Greater Bay Area Investment Fund, Strategic Tech Fund, and Co-Investment Fund—into companies operating in Hard and Core Technology, Biotechnology and Health Technology, New Energy and Green Technology, and Related Sectors and Applications. It pursues a dual mandate of generating reasonable medium- to long-term financial returns while enhancing Hong Kong's long-term competitiveness and economic vitality through direct investments, co-investments, and university-linked specialized funds.

Product overview

Hong Kong Investment Corporation Limited (HKIC) operates as a government-owned Patient Capital institution managing HK$62 billion (approximately US$8 billion) across four main investment portfolios: the Hong Kong Growth Portfolio, Greater Bay Area Investment Fund, Strategic Tech Fund, and Co-Investment Fund. The corporation focuses on three core investment themes—Hard and Core Technology, Biotechnology and Health Technology, and New Energy and Green Technology—plus Relevant Sectors and Applications. HKIC deploys capital through direct investments and co-investments in companies aligned with its dual mandate of seeking reasonable financial returns while enhancing Hong Kong's long-term competitiveness and economic vitality. The corporation also partners with universities and venture capital firms on specialized funds like the Gobi-HKU Fund I and Gobi-Redbird Innovation Fund targeting university spin-offs and early-stage ventures.

Differentiator

Problem solved

Functional benefit

Products and services

• Hong Kong Growth Portfolio (香港增長組合) Strategic investment vehicle targeting investments that benefit Hong Kong and generate long-term returns across HKIC's key investment themes.
• Greater Bay Area Investment Fund (大灣區投資基金) Investment fund targeting the Greater Bay Area region, recognizing Hong Kong's integral role in the area and its potential as a significant growth engine for economic and social benefits to Hong Kong.
• Strategic Tech Fund (策略性創科基金) HK$5 billion fund supporting the development of innovative technologies, crucial for cultivating new productive forces, enhancing economic diversification, and driving growth momentum.
• Co-Investment Fund (共同投資基金) HK$30 billion fund established under the 2022 Policy Address to attract enterprises to set up operations in Hong Kong and promote projects that bring long-term strategic benefits to the city.
• Gobi-HKU Fund I Specialized university-linked venture fund launched with Gobi Partners and the University of Hong Kong targeting early-stage university spin-offs such as Manifold Tech (spatial intelligence for robotics) and AilsynBio (AI-driven drug design).
• Gobi-Redbird Innovation Fund Early-stage university innovation fund launched with HKUST and Gobi Partners to support early-stage university start-ups in Hong Kong focused on biotech, AI, robotics, and fintech sectors.
• AI Creative Fund Joint AI-focused venture fund launched with CMC Capital through a US$130 million investment in LiblibAI, targeting multimodal AI and creative community platforms.
• Offshore RMB Venture Capital Fund

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core and secondary.

• Gobi PartnerscoreStrategic or Co-development PartnerHKIC partnered with Gobi Partners to launch Gobi-HKU Fund I with University of Hong Kong, making first investments in robotics (Manifold Tech) and AI drug design (AilsynBio). Also launched Gobi-Redbird Innovation Fund with HKUST.
• New Frontier Group (新风天域集团)coreStrategic or Co-development PartnerStrategic partnership in life sciences and healthcare. New Frontier to establish corporate VC in Hong Kong, host annual Greater Bay Area-Global Medical Summit, and provide 30+ internship opportunities for Hong Kong students annually.
• Gaw Capital (基汇资本)secondaryStrategic or Co-development PartnerJointly created International Strategic Expansion Platform to accelerate R&D commercialization and help Hong Kong brands expand to Global South markets including Middle East.
• Lanchi Ventures (蓝驰创投)secondaryStrategic or Co-development PartnerEarly-stage technology-focused GP. Jointly created Co-investment Partnership Programme supporting Chinese tech entrepreneurs with global vision to achieve global impact.
• Towngas (香港中华煤气)secondaryStrategic or Co-development PartnerMinority stakeholder in EnerVenue with exclusive distribution rights for EnerVenue's products in mainland China. Strategic investor in EnerVenue's Series B+ round.

Scale indicators9 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Temasek Holdings: Singapore state-owned investment company managing a diversified portfolio across financial services, tech, and sustainability. Directly comparable as a sovereign-backed, multi-thematic patient-capital investor in Asia with a similar dual mandate of returns and strategic national outcomes.
• GIC (Government of Singapore Investment Corporation): Singapore sovereign wealth fund managing Singapore's foreign reserves with long-term, global investment horizon. Closely comparable in structure, scale, and patient-capital orientation to HKIC, with a similar dual-return and policy mandate.
• China Investment Corporation (CIC): Sovereign wealth fund of China managing foreign exchange reserves with long-term horizon. Comparable as a state-owned patient-capital vehicle investing in alternative assets and technology, though operating at substantially larger scale.
• Khazanah Nasional: Sovereign wealth fund of Malaysia investing in strategic sectors to drive national economic outcomes. Comparable as a state-owned investment institution with thematic mandates, ecosystem-building orientation, and regional Asia focus.
• Mubadala Investment Company: Abu Dhabi sovereign investor deploying capital across technology, healthcare, and energy. Comparable as a sovereign-backed, thematic multi-fund platform investing globally in innovation and strategic sectors aligned with national priorities.
• Korea Investment Corporation (KIC): South Korea's sovereign wealth fund managing public funds with diversified global investment strategy. Comparable as an Asia-based state-owned investment corporation with patient-capital characteristics and thematic sector emphasis.

Broad incumbents

• Saudi Public Investment Fund (PIF): One of the largest sovereign wealth funds globally, with broad sector exposure and a similar mandate to drive national economic transformation. Overlaps in thematic focus on tech, green energy, and biotech, but operates at much larger scale and broader geographic scope.
• Qatar Investment Authority (QIA): Qatar's sovereign wealth fund investing across asset classes to diversify the national economy. Comparable in structure and long-horizon patient-capital mandate, though with a more global rather than regional concentration.
• Investment Corporation of Dubai (ICD): Principal investment arm of the Government of Dubai, managing a diversified portfolio of strategic assets. Comparable as a state-owned investment entity balancing financial returns with strategic national economic objectives.

Others

• Gobi Partners: Pan-Asian venture capital firm managing multiple sector-focused funds across tech, fintech, and sustainability. Comparable as a thematic multi-fund platform and a key co-GP partner for HKIC's university-linked funds (Gobi-HKU, Gobi-Redbird).

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments14 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hong Kong Investment Corporation Limited